Zacks Investment Research downgraded shares of GENERAL MOLY IN (GMO) from OUTPERFORM to NEUTRAL on January 02, 2013, with a target price of $4.40.
General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. Their primary asset, their interest in the Mt. Hope project located in central Nevada, is considered one of the world's largest and highest grade molybdenum deposits. Combined with their second molybdenum property, the Hall-Tonopah project which is also located in central Nevada. Their goal is to become the largest primary molybdenum producer by the middle of the next decade.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on GENERAL MOLY IN (GMO),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment